Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.

Autor: Sandborn, W. J.1,2, Bhandari, B. R.3, Fogel, R.4, Onken, J.5, Yen, E.6, Zhao, X.6, Jiang, Z.6, Ge, D.6, Xin, Y.6, Ye, Z.6, French, D.6, Silverman, J. A.6, Kanwar, B.6, Subramanian, G. M.6, McHutchison, J. G.6, Lee, S. D.7, Shackelton, L. M.1, Pai, R. K.8, Levesque, B. G.1, Feagan, B. G.1,9,10
Zdroj: Alimentary Pharmacology & Therapeutics. Jul2016, Vol. 44 Issue 2, p157-169. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje